AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04848259 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dexamethasone and honey
Description: Dexamethason will be given IV before surgery and then Honey will be applied locally after surgery
Study NCT06155513 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Omega-3 monoglyceride based topical Serum and cream of formulation A (light)
Description: Omega-3 monoglyceride based serum and cream of lighter formulation
Study NCT06155513 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Omega-3 monoglyceride based topical Serum and cream of formulation B (rich)
Description: Omega-3 monoglyceride based serum and cream with a richer formulation
Study NCT05551689 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Psychostimulant
Description: All enrolled patients should be receiving ADHD pharmacological treatment (psychostimulants)
Study NCT05551689 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Psychostimulant
Description: All enrolled patients should be receiving ADHD pharmacological treatment (psychostimulants)
Study NCT05551689 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: FOCUS ADHD App
Description: FOCUS ADHD is a mobile health application to support ADHD treatment adherence, monitoring and psychoeducation. The App was developed by the Attention Deficit Hyperactivity Disorder Program (ProDAH) of the Hospital de Clínicas de Porto Alegre (HCPA) and the Federal University of Rio Grande do Sul (UFRGS)
Study NCT06025994 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: MULTI-DOMAIN LIFESTILE INTERVENTION
Description: All participants in the multi-domain lifestyle group will receive five different kinds of intervention: i) strict management of CV and metabolic risk factors, ii) tailoring of medical therapy on the basis of the invasive assessment of CMD and coronary vasomotion, iii) exercise training iv) dietary counselling, v) psychological intervention.
Study NCT05294406 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Intermittent preventive treatment in pregnancy (IPTp) with dihydroartemisinin-piperaquine
Description: Pregnant women attending routine antenatal care visits in their second and third trimester are given monthly IPTp consisting of a treatment dose of dihydroartemisinin-piperaquine (3 tablets per day for 3 days, 9 tablets total)
Study NCT06294665 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Pericapsular Nerve Group (PENG) Block
Description: The PENG block will be performed ,the patient is placed in the supine position , the procedural leg is slightly abducted, the curvilinear low-frequency ultrasound probe will be placed over the line parallel to the inguinal ligament. It will subsequently rotated 45◦ to identify the anterior inferior iliac spine, the iliopubic eminence, and the psoas tendon. A 22-gauge, 80 mm echogenic needle will inserted in an in-plane approach to place the tip in the musculofascial plane between the pubic ramus posteriorly and the psoas tendon anteriorly. Following negative aspiration, by one of the two syringes each one has a serial number corresponding to each group.
Study NCT05622227 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Drug: 68Ga-P16-093
Description: Intravenous injection of 68Ga-P16-093 with the dosage of 1.5-1.8 MBq (0.04-0.05 mCi)/kg. Tracer doses of 68Ga-P16-093 will be used to image lesions of breast cancer by PET/CT.
Study NCT06436391 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Kinesio taping
Description: Kinesio taping will be applied to the lateral part of the baby's heel to increase blood flow. Blood collection will always be performed by the same nurse
Study NCT06436391 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: ShotBlocker
Description: Shotblocker will be applied to the baby's heel average 10-15 seconds with minimal pressure.
Study NCT04933617 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Rituximab
Description: Rituximab 375 mg/m\^2 intravenous (IV) per protocol on Day 1 of each cycle up to 6 cycles
Study NCT04933617 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Etoposide
Description: Etoposide 50 mg/m\^2/day continuous intravenous infusion (CIVI) on Days 1-4 of each cycle up to 6 cycles
Study NCT04933617 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Copanlisib
Description: Copanlisib intravenous (IV) is administered at a fixed dose (30 mg, 45 mg, or 60 mg) on days 1 and 5 of each 21-day cycle for up to 6 cycles
Study NCT04933617 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Description: Cyclophosphamide 750 mg/m\^2 intravenous (IV) on Day 5 of each cycle up to 6 cycles
Study NCT04933617 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Doxorubicin
Description: Doxorubicin 10 mg/m\^2/day continuous intravenous infusion (CIVI) on Days 1-4 of each cycle up to 6 cycles
Study NCT04933617 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vincristine
Description: Vincristine 0.4 mg/m\^2/day (no cap) continuous intravenous infusion (CIVI) on Days 1-4 of each cycle up to 6 cycles
Study NCT04933617 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Prednisone
Description: Prednisone 60 mg/m\^2 by mouth (PO) twice a day (BID) Days 1-5 (total 120mg/m\^2/day)
Study NCT04933617 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: ECHO
Description: At screening.
Study NCT04933617 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: EKG
Description: At screening.
Study NCT04933617 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: MRI Brain
Description: At screening.
Study NCT04933617 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: 18F-FDG - PET
Description: At screening, baseline, after cycle 1, 3, and 6, and end of treatment.
Study NCT04933617 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: CT Scan
Description: At screening, baseline, after cycle 1, 3, and 6, end of treatment and follow-up.
Study NCT04933617 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Bone Marrow Aspiration
Description: At screening and end of treatment.
Study NCT04933617 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Bone Marrow Biopsy
Description: At screening and end of treatment.
Study NCT04933617 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Lumbar Puncture (LP)
Description: Baseline and end of treatment.
Study NCT06356818 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional physiotherapy program
Description: Physiotherapy and rehabilitation treatment program will be applied to the patients. In this program, a 30-40-minute exercise protocol covering proprioceptive, balance and strengthening exercises will be implemented. For a total of 12 sessions, 3 days a week, over a 4-week period
Study NCT06356818 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Virtual reality (VR)
Description: virtual reality (VR) program will be applied using balance and strengthening games by Nintendo Wii Fit Plus; warm-up exercise (5 minutes), workout (20 minutes) and cool-down exercise (5 minutes) for a total of 30 minutes. For a total of 12 sessions, 3 days a week, over a 4-week period
Study NCT06356818 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Motor imagery (MI)
Description: Patients will be introduced to explicit Motor imagery program which the content of the imagery program will last 20 minutes in total, with 5 minutes of relaxation and 15 minutes of imagery training. For a total of 12 sessions, 3 days a week, over a 4-week period.
Study NCT06536322 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: OHS-interRAI
Description: An oral health screening tool is being tested. Former name was the optimized oral health-related section of the interRAI (ohr-interRAI). This was further optimized into the OHS-interRAI. The OHS-interRAI comprises of 3 oral health-related items that are assessed through questioning the resident, and 6 items that require visual inspection of the mouth.
Study NCT05786638 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Allergen Immunotherapy Extract
Description: Sublingual subcutaneous allergen immunotherapy
Study NCT05030636 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Acute moderate to vigorous exercise performed at a specific moment of the day
Description: Treadmill (30 minutes) at 70% of maximal aerobic capacity
Study NCT05039801 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Bevacizumab
Description: Given IV
Study NCT05039801 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Glutaminase-1 Inhibitor IACS-6274
Description: Given by PO
Study NCT05039801 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paclitaxel
Description: Given by IV (vein)
Study NCT05039801 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Capivasertib
Description: Given by PO
Study NCT04893460 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: CoQuit App
Description: The CoQuit App is a cognitive dissonance based app for smoking cessation.
Study NCT05691959 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Patients randomized to placebo group will receive Normal Saline 50ml IV.
Study NCT05691959 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Calcium
Description: Patients randomized to the study group will receive Calcium 2gm in Normal Saline 50ml IV.
Study NCT06497504 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bepirovirsen
Description: Bepirovirsen will be administered.
Study NCT06497504 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo will be administered.
Study NCT06510920 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Aerobic exercise
Description: The mixed design scheme of football and volleyball sports technology and competition will be adopted.aerobic exercise intensity will be moderate-intensity aerobic exercise load , and the intervention time was 12 weeks, 60 minutes each time, twice a week. The main preparation activities were jogging and special preparation activities (10 minutes), and the main part was technical teaching combined with competition (60 minutes).The end part is mostly jogging and stretching (10 minutes). Two subjects in each group were selected to wear Decathlon Bluetooth heart rate band, and the exercise intensity was controlled by detecting the heart rate of the subjects.
Study NCT06261541 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: ABLE Exoskeleton
Description: Participants with MS will undergo a training program with the ABLE Exoskeleton device: a total of 10 sessions, distributed 1-2 sessions/week for up to 11 weeks.
Study NCT05621967 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Tonation Breathing Techniques
Description: Tonation and Breathing Techniques (TBT): consist of a combination of organic inhalation and controlled exhalation with tonation. This will be guided by a trained facilitator, and the entire exercise will take 20 minutes. This will include guided relaxed breathing, mindful breathing, patterned tonation, nasal tonation, and pursed lip tonation.
Study NCT05621967 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Music Driven Vocal Exercises
Description: Music Driven Vocal Exercises (MDVE): A Music Therapy procedure will be implemented by a trained facilitator, utilizing an accompanying instrument (ie, guitar or Autoharp) and moving stepwise up and down within a scale of 8 whole steps. The total length of the procedure is 20-25 minutes. This will include vocal exercises, and melodic exercises alternating with speaking,
Study NCT05621967 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Silent Breathing
Description: Patient will sit in a quiet room and focus on silent breathing x 20 min.
Study NCT05070143 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: RISE-UP Routine
Description: The participants in this condition will be instructed to substitute their current sleep habits with the RISE-UP routine that has been developed by our team (Kaplan, Talavera, \& Harvey, 2018). This involves instructing participants to devise an individually tailored routine that will help them get up each morning (e.g., open blinds, make the bed, head for the shower).
Study NCT05070143 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Awareness Training
Description: The participants in this condition will be instructed in dismantling/disrupting the association between the cue and the habit via awareness training from habit reversal approaches (Azrin \& Nunn, 1973; Ladouceur, 1979). This condition involves instructing the participant to develop an awareness of their decisions to stay in bed and snooze.
Study NCT05070143 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Vigilant Monitoring
Description: The participants in this condition will be instructed in vigilant monitoring which involves internal repetition of get up! and don't do it and watching carefully for slipups (Quinn, Pascoe, Wood, \& Neal, 2010).
Study NCT05070143 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Implementation Intentions
Description: The participants in this condition will be instructed in counter habitual implementation intentions. This involves instructing the participant to engage in implementation intentions in which they imagine replacing snoozing with getting up out of bed (Adriaanse, Gollwitzer, De Ridder, De Wit, \& Kroese, 2011). The structure of this implementation intention is: If I wake up in the morning and I want a sleep-in then I will get up and start my day.
Study NCT05070143 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Values-based Approach
Description: The participants in this condition will be instructed in a values-based approach (Anshel, Brinthaupt, \& Kang, 2010; Anshel \& Kang, 2007). This involves asking the participants to reflect on how getting up consistently at the same time each day does or does not align with their values. They are asked to compare the costs and long-term consequences of continuing to engage in the unwanted habit and clearly articulating the disconnect between the habit and their values.
Study NCT05070143 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Brief Education
Description: In this condition, participants only receive the learning module. This condition is included as a minimal intervention comparison condition that controls for the passage of time.~First, education about the importance of regular wake times and sleep inertia that is a normal transitional stage between sleep and wake. The education will be delivered in this video format: https://www.youtube.com/watch?v=P6zcSFA7ymo. Second, after viewing the video, the key points will be summarized. Lastly, participants will be asked to summarize the four key takeaways for good sleep habits.
Study NCT05971628 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: RAPID procedure
Description: RAPID procedure stands for Resection And Partial Liver Transplantation with Delayed Hepatectomy for hepatocellular carcinoma
Study NCT04733898 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: SamenSpelen.app
Description: An app designed to play simple, social games in a chat environment. These games are designed to elicit personal interaction.
Study NCT04733898 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: FijnSpelen.app
Description: An app designed to play simple, social games in a chat environment. These games are designed to not elicit personal interaction.
Study NCT05336513 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Diet Control
Description: Diet following mediterranean principles, for 15 weeks
Study NCT05336513 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Diet anti-inflammatory
Description: Diet combining food items with anti-inflammatory potential, following the principles described in Rondanelli, Clinical Nutrition, 2021 Mar;40(3):661-689. doi: 10.1016/j.clnu.2020.08.020.
Study NCT05219929 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Tetracycline 500 Mg
Description: 500 mg three times daily
Study NCT05219929 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tetracycline 500 Mg
Description: 500 mg three times daily
Study NCT05219929 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo for Tetracycline given same way as Tetracycline.
Study NCT05219929 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Placebo
Description: Placebo for Tetracycline given same way as Tetracycline.
Study NCT05082844 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: MRI assessment
Description: Evaluation of the clinical-radiological results from the case series of patients surgically treated for cuff rotator lesions from 2009 to 2020 at the Shoulder-Elbow Department . At 12 months the result is considered stabilized, so we will proceed to collect all case histories that have passed this follow-up period.
Study NCT05715736 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: APB-R3
Description: APB-R3 is formulated as a sterile solution containing APB-R3 as the active substance administered intravenously.
Study NCT05715736 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 0.90% Normal Saline only
Study NCT06097273 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: mRNA-1083
Description: Suspension for injection
Study NCT06168162 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: titated PEEP to best static compliance
Description: the Intraoperative PEEP will be titrated to best static compliance for each patient
Study NCT06168162 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: titated PEEP to best static compliance
Description: the Intraoperative PEEP will be titrated to best static compliance for each patient
Study NCT04991688 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BOTOX-A
Description: 10 injections of 20 U of toxin will be made into the rectum 5, 10 and 15 cm above the pectinate line. At each level, 3 injections of 20 U will be performed in the submucosa, circumferentially.The last injection is made 20 cm above the pectinate line. Total does not exceed 200U of Botox-A
Study NCT05330351 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Gastric Ultrasound
Description: The investigators will compare gastric fluid volume as determined by ultrasound pre-induction vs. gastric volume aspirated via an orogastric tube post-intubation. The results will be stratified into low risk, moderate risk and high risk for aspiration based on ultrasound exam by an investigator off-line.
Study NCT04839614 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: CONCURRENT LAPAROSCOPIC HYSTERECTOMY AND WEIGHT LOSS SURGERY-Referral
Description: See arm description
Study NCT05734742 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Educational video
Description: There were two videos including the first video Sleep apnea Syndrome Driving Safety Picture Scroll and the second video Sleep apnea Syndrome and Traffic Accidents. The first video was approximately 3 minutes long. This video was suitable for all ages. It was an easy-to-understand video explaining the characteristics of OSA and its relationship with traffic accidents. The second video was the detailed video, which is approximately 20 minutes in duration. This video was suitable for those who desire to learn more about OSA. It can be used in various educational settings, including internal training and traffic safety workshops. Participants must watch at least the first video.
Study NCT06088797 — intervention group
Intervention type: OTHER
Intervention: METRIC COMPARISON Tasks : Tactile PVSE test
Description: Tactile PVSE test The tests are presented in 6 independent booklets, each of which tests a distinct skill: comparison of lengths, comparison of sizes, comparison of obliques, perception of environments, comparison of relative positions in relation to a frame and comparison of relative positions with distractors.~The assessment sheet presented in a table with the expected answers will allow you to note whether the answers are correct (rating 1) or not (rating 0). A total of the correct answers from all the sub-tests will give a total score.
Study NCT06088797 — intervention group
Intervention type: OTHER
Intervention: METRIC COMPARISON Tasks : Classic PVSE test
Description: Classic PVSE test Use of the standardized PVSE test printed on thick white paper in 6 separate booklets each containing a subtest (length, size, oblique, middle, relative position and relative position with distractor)~The assessment sheet presented in a table with the expected answers will allow you to note whether the answers are correct (rating 1) or not (rating 0). A total of the correct answers from all the sub-tests will give a total score.
Study NCT06088797 — intervention group
Intervention type: OTHER
Intervention: Mental imagery task
Description: This involves answering questions concerning the position or identity of 2 or 3 objects on the basis of the mental representation of a grid by auditory guidance. Each grid must be constructed mentally with the verbal description of the path and the objects encountered.
Study NCT06088797 — intervention group
Intervention type: OTHER
Intervention: Proprioceptive spatial representation tasks
Description: 16 configurations of 3 objects with direct or indirect passive exploration of their relative positions.~Each grid is presented 3 times with the following 3 questions to which the subject answers yes or no by forced choice~a single measure of the number of correct answers which will be the sum of the correct answers obtained to each of the 3 questions in the direct vs indirect condition